Indiana University School of Medicine-Indianapolis

Indianapolis, Indiana 46202-2266

2 studies enrolling now · 7 studies all time

What they study most

Alpha1-Antitrypsin Deficiency, Cardiac Failure, Compensated Cirrhosis, Crohn's Disease, Glioma, H3 K27M, Heart Failure, Hereditary Transthyretin-Mediated Amyloid Polyneuropathy, Primary Biliary Cholangitis, Reduced Ventricular Ejection Fraction, Ulcerative Colitis

Studies at this site

• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
• ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) — Recruiting now
• Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis) — Recruiting now
• A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis. — Completed
• NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy — Completed
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) — Completed
• A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function — Completed